{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:14:46Z","timestamp":1760955286048,"version":"3.38.0"},"reference-count":68,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2004]]},"DOI":"10.5551\/jat.11.41","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"41-48","source":"Crossref","is-referenced-by-count":45,"title":["Neuronal Nitric Oxide Synthase as a Novel Anti-Atherogenic Factor"],"prefix":"10.5551","volume":"11","author":[{"given":"Masato","family":"Tsutsui","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Occupational and Environmental Health, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"(1) Bredt DS and Snyder SH: Nitric oxide: a physiological messenger molecule. Annu Rev Biochem, 63: 175−195, 1994","DOI":"10.1146\/annurev.bi.63.070194.001135"},{"key":"2","doi-asserted-by":"crossref","unstructured":"(2) Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest, 100: 2153−2157, 1997","DOI":"10.1172\/JCI119751"},{"key":"3","unstructured":"(3) Luscher TF and Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function, CRC Press, Boca Raton, FL, 1990"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Shimokawa H: Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol, 31: 23−37, 1999","DOI":"10.1006\/jmcc.1998.0841"},{"key":"5","doi-asserted-by":"crossref","unstructured":"(5) Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res, 31: 131−143, 1994","DOI":"10.1159\/000159039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"(6) Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S, Egashira K, Huang P, Akaike T, and Takeshita A: Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol, 20: E96−E100, 2000","DOI":"10.1161\/01.ATV.20.11.e96"},{"key":"7","doi-asserted-by":"crossref","unstructured":"(7) Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, and Huang PL: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest, 101: 1225−1232, 1998","DOI":"10.1172\/JCI1293"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(8) Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, and Sessa WC: Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest, 101: 731−736, 1998","DOI":"10.1172\/JCI1699"},{"key":"9","doi-asserted-by":"crossref","unstructured":"(9) Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, Hayashi Y, Itoh H, and Yokoyama M: Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol, 21: 201−207, 2001","DOI":"10.1161\/01.ATV.21.2.201"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA, 92: 1137−1141, 1995","DOI":"10.1073\/pnas.92.4.1137"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) Koglin J, Glysing-Jensen T, Mudgett JS, and Russell ME: Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation, 97: 2059−2065, 1998","DOI":"10.1161\/01.CIR.97.20.2059"},{"key":"12","doi-asserted-by":"crossref","unstructured":"(12) Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, and Cercek B: Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res, 85: 1192−1198, 1999","DOI":"10.1161\/01.RES.85.12.1192"},{"key":"13","doi-asserted-by":"crossref","unstructured":"(13) Kuhlencordt PJ, Chen J, Han F, Astern J, and Huang PL: Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation, 103: 3099−3104, 2001","DOI":"10.1161\/01.CIR.103.25.3099"},{"key":"14","doi-asserted-by":"crossref","unstructured":"(14) Goss SP, Hogg N, and Kalyanaraman B: The effect of nitric oxide release rates on the oxidation of human low density lipoprotein. J Biol Chem, 272: 21647−21653, 1997","DOI":"10.1074\/jbc.272.34.21647"},{"key":"15","doi-asserted-by":"crossref","unstructured":"(15) Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, and Pritchard KA, Jr: Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A, 95: 9220−9225, 1998","DOI":"10.1073\/pnas.95.16.9220"},{"key":"16","doi-asserted-by":"crossref","unstructured":"(16) Wang W, Wang S, Yan L, Madara P, Del Pilar Cintron A, Wesley RA, and Danner RL: Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem, 275: 16899−16903, 2000","DOI":"10.1074\/jbc.M000301200"},{"key":"17","doi-asserted-by":"crossref","unstructured":"(17) Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, and Marsden PA: Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol, 17: 2479−2488, 1997","DOI":"10.1161\/01.ATV.17.11.2479"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(18) Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, and Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351: 714−718, 1991","DOI":"10.1038\/351714a0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"(19) Bredt DS and Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA, 87: 682−690, 1990","DOI":"10.1073\/pnas.87.2.682"},{"key":"20","doi-asserted-by":"crossref","unstructured":"(20) Morishita T, Tsutsui M, Shimokawa H, Horiuchi M, Tanimoto A, Suda O, Tasaki H, Huang PL, Sasaguri Y, Yanagihara N, and Nakashima Y: Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J, 16: 1994−1996, 2002","DOI":"10.1096\/fj.02-0155fje"},{"key":"21","doi-asserted-by":"crossref","unstructured":"(21) Albrecht EW, Stegeman CA, Heeringa P, Henning RH, and van Goor H: Protective role of endothelial nitric oxide synthase. J Pathol, 199: 8−17, 2003","DOI":"10.1002\/path.1250"},{"key":"22","doi-asserted-by":"crossref","unstructured":"(22) Iadecola C: Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci, 16: 206−214, 1993","DOI":"10.1016\/0166-2236(93)90156-G"},{"key":"23","doi-asserted-by":"crossref","unstructured":"(23) Toda N and Okamura T: Nitroxidergic nerve: regulation of vascular tone and blood flow in the brain. J Hypertens, 14: 423−434., 1996","DOI":"10.1097\/00004872-199604000-00003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"(24) Lee TJ, Liu J, and Evans MS: Cholinergic-nitrergic transmitter mechanisms in the cerebral circulation. Microsc Res Tech, 53: 119−128, 2001","DOI":"10.1002\/jemt.1076"},{"key":"25","doi-asserted-by":"crossref","unstructured":"(25) Bardell AL and MacLeod KM: Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther, 296: 252−259, 2001","DOI":"10.1016\/S0022-3565(24)38787-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"(26) Kolyada AY, Fedtsov A, and Madias NE: 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Hypertension, 38: 1024−1029, 2001","DOI":"10.1161\/hy1101.093103"},{"key":"27","doi-asserted-by":"crossref","unstructured":"(27) Luscher TF and Barton M: Biology of the endothelium. Clin Cardiol, 20: II-3−II-10, 1997","DOI":"10.1002\/clc.4960200103"},{"key":"28","doi-asserted-by":"crossref","unstructured":"(28) Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, Baba HA, Robenek H, Schnekenburger J, and Lerch MM: Vascular smooth muscle and nitric oxide synthase. FASEB J, 16: 500−508, 2002","DOI":"10.1096\/fj.01-0842com"},{"key":"29","doi-asserted-by":"crossref","unstructured":"(29) Bobrow MN, Harris TD, Shaughnessy KJ, and Litt GJ: Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods, 125: 279−285, 1989","DOI":"10.1016\/0022-1759(89)90104-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"(30) Adams JC: Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem, 40: 1457−1463, 1992","DOI":"10.1177\/40.10.1527370"},{"key":"31","doi-asserted-by":"crossref","unstructured":"(31) Hopman AH, Ramaekers FC, and Speel EJ: Rapid synthesis of biotin-, digoxigenin-, trinitrophenyl-, and fluorochrome-labeled tyramides and their application for In situ hybridization using CARD amplification. J Histochem Cytochem, 46: 771−777, 1998","DOI":"10.1177\/002215549804600611"},{"key":"32","doi-asserted-by":"crossref","unstructured":"(32) von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, and Georgii A: Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem, 45: 1455−1459, 1997","DOI":"10.1177\/002215549704501102"},{"key":"33","doi-asserted-by":"crossref","unstructured":"(33) Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, and Vanhoutte PM: Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res, 83: 1271−1278, 1998","DOI":"10.1161\/01.RES.83.12.1271"},{"key":"34","doi-asserted-by":"crossref","unstructured":"(34) Tambascia RC, Fonseca PM, Corat PD, Moreno H, Jr, Saad MJ, and Franchini KG: Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension, 37: 1423−1428, 2001","DOI":"10.1161\/01.HYP.37.6.1423"},{"key":"35","doi-asserted-by":"crossref","unstructured":"(35) Loesch A and Burnstock G: Ultrastructural localization of nitric oxide synthase and endothelin in rat pulmonary artery and vein during postnatal development and ageing. Cell Tissue Res, 283: 355−365, 1996","DOI":"10.1007\/s004410050546"},{"key":"36","doi-asserted-by":"crossref","unstructured":"(36) Schwarz PM, Kleinert H, and Forstermann U: Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. Arterioscler Thromb Vasc Biol, 19: 2584−2590, 1999","DOI":"10.1161\/01.ATV.19.11.2584"},{"key":"37","doi-asserted-by":"crossref","unstructured":"(37) Brophy CM, Knoepp L, Xin J, and Pollock JS: Functional expression of NOS 1 in vascular smooth muscle. Am J Physiol Heart Circ Physiol, 278: H991−H997, 2000","DOI":"10.1152\/ajpheart.2000.278.3.H991"},{"key":"38","doi-asserted-by":"crossref","unstructured":"(38) Papadaki M, Tilton RG, Eskin SG, and McIntire LV: Nitric oxide production by cultured human aortic smooth muscle cells: stimulation by fluid flow. Am J Physiol, 274: H616−H626, 1998","DOI":"10.1152\/ajpheart.1998.274.2.H616"},{"key":"39","doi-asserted-by":"crossref","unstructured":"(39) Moore PK, al-Swayeh OA, Chong NW, Evans RA, and Gibson A: L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol, 99: 408−412, 1990","DOI":"10.1111\/j.1476-5381.1990.tb14717.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"(40) Moore PK, Wallace P, Gaffen Z, Hart SL, and Babbedge RC: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol, 110: 219−224, 1993","DOI":"10.1111\/j.1476-5381.1993.tb13795.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"(41) Furfine ES, Harmon MF, Paith JE, Knowles RG, Salter M, Kiff RJ, Duffy C, Hazelwood R, Oplinger JA, and Garvey EP: Potent and selective inhibition of human nitric oxide synthases: selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem, 269: 26677−26683, 1994","DOI":"10.1016\/S0021-9258(18)47072-X"},{"key":"42","doi-asserted-by":"crossref","unstructured":"(42) Jaffrey SR and Snyder SH: PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science, 274: 774−777, 1996","DOI":"10.1126\/science.274.5288.774"},{"key":"43","doi-asserted-by":"crossref","unstructured":"(43) Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, and Snyder SH: CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron, 20: 115−124, 1998","DOI":"10.1016\/S0896-6273(00)80439-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"(44) Venema VJ, Ju H, Zou R, and Venema RC: Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding\/inhibitory domain. J Biol Chem, 272: 28187−28190, 1997","DOI":"10.1074\/jbc.272.45.28187"},{"key":"45","doi-asserted-by":"crossref","unstructured":"(45) Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, and Sessa WC: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem, 272: 25437−25440, 1997","DOI":"10.1074\/jbc.272.41.25437"},{"key":"46","doi-asserted-by":"crossref","unstructured":"(46) Papapetropoulos A, Rudic RD, and Sessa WC: Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res, 43: 509−520, 1999","DOI":"10.1016\/S0008-6363(99)00161-3"},{"key":"47","unstructured":"(47) Stanarius A, Seidel B, and Wolf G: Neuronal nitric oxide synthase in the vasculature of the rat brain: an immunocytochemical study using the tyramide signal amplification technique. J Neurocytol, 27: 731−736, 1998"},{"key":"48","unstructured":"(48) Loesch A and Burnstock G: Perivascular nerve fibres and endothelial cells of the rat basilar artery: immuno-gold labelling of antigenic sites for type I and type III nitric oxide synthase. J Neurocytol, 27: 197−204, 1998"},{"key":"49","doi-asserted-by":"crossref","unstructured":"(49) Benyo Z, Lacza Z, Hortobagyi T, Gorlach C, and Wahl M: Functional importance of neuronal nitric oxide synthase in the endothelium of rat basilar arteries. Brain Res, 877: 79−84, 2000","DOI":"10.1016\/S0006-8993(00)02611-1"},{"key":"50","doi-asserted-by":"crossref","unstructured":"(50) Guthrie GP, Jr: Angiotensin receptors: physiology and pharmacology. Clin Cardiol, 18 (Suppl III): III-29−III-34, 1995","DOI":"10.1002\/clc.4960181507"},{"key":"51","doi-asserted-by":"crossref","unstructured":"(51) Brock TA, Alexander RW, Ekstein LS, Atkinson WJ, and Gimbrone MA Jr: Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension, 7: I105−I109, 1985","DOI":"10.1161\/01.HYP.7.3_Pt_2.I105"},{"key":"52","doi-asserted-by":"crossref","unstructured":"(52) Mitsuhashi T, Morris RC, Jr, and Ives HE: Endothelin-induced increases in vascular smooth muscle Ca2+<\/SUP> do not depend on dihydropyridine-sensitive Ca2+<\/SUP> channels. J Clin Invest, 84: 635−639, 1989","DOI":"10.1172\/JCI114209"},{"key":"53","unstructured":"(53) Hoetten S, Hu K, Widder J, Riehl G, Marx A, Huang PL, Ertl G, and Kuhlencordt PJ: Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein E knockout mice. Circulation, 108: IV-40 (abstract), 2003"},{"key":"54","doi-asserted-by":"crossref","unstructured":"(54) Meng W, Ayata C, Waeber C, Huang PL, and Moskowitz MA: Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am J Physiol, 274: H411−H415, 1998","DOI":"10.1152\/ajpheart.1998.274.2.H411"},{"key":"55","doi-asserted-by":"crossref","unstructured":"(55) Huang A, Sun D, Shesely EG, Levee EM, Koller A, and Kaley G: Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am J Physiol Heart Circ Physiol, 282: H429−H436, 2002","DOI":"10.1152\/ajpheart.00501.2001"},{"key":"56","doi-asserted-by":"crossref","unstructured":"(56) Lamping KG, Nuno DW, Shesely EG, Maeda N, and Faraci FM: Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol, 279: H1906−H1912, 2000","DOI":"10.1152\/ajpheart.2000.279.4.H1906"},{"key":"57","doi-asserted-by":"crossref","unstructured":"(57) Rosenfeld CR, Chen C, Roy T, and Liu X: Estrogen selectively up-regulates eNOS and nNOS in reproductive arteries by transcriptional mechanisms. J Soc Gynecol Investig, 10: 205−215, 2003","DOI":"10.1016\/S1071-5576(03)00049-2"},{"key":"58","doi-asserted-by":"crossref","unstructured":"(58) Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, and Huang PL: Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE\/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol, 23: 97−103, 2003","DOI":"10.1161\/01.ATV.0000040223.74255.5A"},{"key":"59","doi-asserted-by":"crossref","unstructured":"(59) Suda O, Tsutsui M, Morishita T, Tanimoto A, Horiuchi M, Tasaki H, Huang PL, Sasaguri Y, Yanagihara N, and Nakashima Y: Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation, 106: 1729−1735, 2002","DOI":"10.1161\/01.CIR.0000029749.16101.44"},{"key":"60","unstructured":"(60) Tsutsui M, Suda O, Morishita T, Nakata S, Tasaki H, Yanagihara N, and Nakashima Y: Direct evidence for the NO-independent actions of asymmetric dimethylarginine in vascular lesion formation in vivo. Circulation, 108: IV−255, 2003"},{"key":"61","doi-asserted-by":"crossref","unstructured":"(61) Wang Y, Newton DC, and Marsden PA: Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol, 13: 21−43, 1999","DOI":"10.1615\/CritRevNeurobiol.v13.i1.20"},{"key":"62","doi-asserted-by":"crossref","unstructured":"(62) Forstermann U, Boissel JP, and Kleinert H: Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J, 12: 773−790, 1998","DOI":"10.1096\/fasebj.12.10.773"},{"key":"63","doi-asserted-by":"crossref","unstructured":"(63) Boissel JP, Schwarz PM, and Forstermann U: Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide, 2: 337−349, 1998","DOI":"10.1006\/niox.1998.0189"},{"key":"64","unstructured":"(64) Nakata S, Tsutsui M, Morishita T, Suda O, Tasaki H, Yanagihara N, and Nakashima Y: Neuronal nitric oxide synthase is subject to expressional regulation by inflammatory stimuli in vascular smooth muscle cells in rats. Circ J, 67: 139 (abstract), 2003"},{"key":"65","doi-asserted-by":"crossref","unstructured":"(65) Ebrahimian T, Mathieu E, Silvestre JS, and Boulanger CM: Intraluminal pressure increases vascular neuronal nitric oxide synthase expression. J Hypertens, 21: 937−942, 2003","DOI":"10.1097\/00004872-200305000-00018"},{"key":"66","doi-asserted-by":"crossref","unstructured":"(66) Qian H, Neplioueva V, Shetty GA, Channon KM, and George SE: Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation, 99: 2979−2982, 1999","DOI":"10.1161\/01.CIR.99.23.2979"},{"key":"67","doi-asserted-by":"crossref","unstructured":"(67) West NE, Qian H, Guzik TJ, Black E, Cai S, George SE, and Channon KM: Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation, 104: 1526−1532, 2001","DOI":"10.1161\/hc3801.095693"},{"key":"68","doi-asserted-by":"crossref","unstructured":"(68) Channon KM, Qian H, Neplioueva V, Blazing MA, Olmez E, Shetty GA, Youngblood SA, Pawloski J, McMahon T, Stamler JS, and George SE: In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-Fed rabbits. Circulation, 98: 1905−1911, 1998","DOI":"10.1161\/01.CIR.98.18.1905"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/2\/11_2_41\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:56:36Z","timestamp":1741244196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/2\/11_2_41\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.11.41","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2004]]}}}